Checkpoint immunotherapy rejects primary tumors without cDC1 cells or lasting immune memory
A new study has revealed that immune checkpoint blockade can drive the first wave of tumor rejection even when a ...
A new study has revealed that immune checkpoint blockade can drive the first wave of tumor rejection even when a ...
In the relentless pursuit of more effective cancer immunotherapies, researchers have made a groundbreaking discovery that redefines our understanding of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine